Genprex Inc (GNPX)
2.46
+0.10
(+4.24%)
USD |
NASDAQ |
May 03, 12:47
Genprex Price to Book Value: 0.6337 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 02, 2024 | 0.6079 |
| May 01, 2024 | 0.5822 |
| April 30, 2024 | 0.5847 |
| April 29, 2024 | 0.5899 |
| April 26, 2024 | 0.5693 |
| April 25, 2024 | 0.5461 |
| April 24, 2024 | 0.5693 |
| April 23, 2024 | 0.595 |
| April 22, 2024 | 0.5572 |
| April 19, 2024 | 0.5487 |
| April 18, 2024 | 0.5717 |
| April 17, 2024 | 0.5693 |
| April 16, 2024 | 0.5925 |
| April 15, 2024 | 0.6053 |
| April 12, 2024 | 0.6903 |
| April 11, 2024 | 0.7161 |
| April 10, 2024 | 0.7419 |
| April 09, 2024 | 0.7908 |
| April 08, 2024 | 0.7625 |
| April 05, 2024 | 0.7728 |
| April 04, 2024 | 0.7702 |
| April 03, 2024 | 0.8011 |
| April 02, 2024 | 0.7316 |
| April 01, 2024 | 0.765 |
| March 28, 2024 | 0.7676 |
| Date | Value |
|---|---|
| March 27, 2024 | 0.6981 |
| March 26, 2024 | 0.7058 |
| March 25, 2024 | 0.7728 |
| March 22, 2024 | 0.7882 |
| March 21, 2024 | 0.7779 |
| March 20, 2024 | 0.7013 |
| March 19, 2024 | 0.7955 |
| March 18, 2024 | 0.9626 |
| March 15, 2024 | 0.8094 |
| March 14, 2024 | 0.8335 |
| March 13, 2024 | 0.8395 |
| March 12, 2024 | 0.8435 |
| March 11, 2024 | 0.9417 |
| March 08, 2024 | 0.8475 |
| March 07, 2024 | 0.8515 |
| March 06, 2024 | 0.8775 |
| March 05, 2024 | 0.8255 |
| March 04, 2024 | 0.8495 |
| March 01, 2024 | 0.8976 |
| February 29, 2024 | 0.8615 |
| February 28, 2024 | 0.8355 |
| February 27, 2024 | 0.8415 |
| February 26, 2024 | 0.8836 |
| February 23, 2024 | 0.8735 |
| February 22, 2024 | 0.8816 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.5461
Minimum
Apr 25 2024
67.68
Maximum
Feb 25 2020
4.076
Average
2.676
Median
Price to Book Value Benchmarks
| Jaguar Health Inc | 18.24 |
| FibroGen Inc | -- |
| BioXcel Therapeutics Inc | -- |
| TFF Pharmaceuticals Inc | 0.5556 |
| 4D Molecular Therapeutics Inc | 4.257 |
Price to Book Value Related Metrics
| Price | 2.46 |
| Earnings Yield | -917.1% |
| Market Cap | 4.700M |